Germany· DE-A57-a6b2ce3551318fa5
Ebastel
A ebastine product containing ebastine, registered in Germany by Almirall, S.A.. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Ebastine is registered in 13 of 19 countries.
Countries holding a registration under ATC R06AX22 (ebastine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Ebastine · ATC R06AX22
13 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
Price per daily dose
What a daily dose of ebastine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.15 in France to $0.27 in Italy — a ×1.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ebastine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- IT Italy$0.27
- FR France$0.15
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ebastine
- Manufacturer
- Almirall, S.A.
- Country
- Germany (DE)
- ATC code
- R06AX22
- ATC class
- Ebastine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ebastine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALASTINA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULAUxa Farma S.A.
- SwedenEbastin ABECE 10 mg Munsönderfallande tablettEvolan Pharma AB
- FranceEBASTINE ARROW 10 mg, comprimé orodispersibleARROW GENERIQUES
- BelgiumEbastine Sandoz 10 mgSandoz
- ItalyCLEVERALMIRALL S.A.
- NetherlandsEbastine Aurobindo Smelt 10 mg, orodispergeerbare tablettenAurobindo Pharma B.V.
- FinlandEbastin OrionOrion Corporation
- NorwayEbastin OrifarmOrifarm Generics A/S
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Ebastine Filmtabletten Teva, Ebastine Sandoz
- Cyprus · Ebastel
- Denmark · Ebastin "brown", Ebastin Brown
- Estonia · Kestine
- Spain · Bactil, Bactil Flas
- Finland · Ebastin Orion, Kestine
- France · Ebastine Arrow, Ebastine Arrow Lab
- Greece · Kestine, Kestine Flash
- Iceland · Kestine, Kestine Flash
- Italy · Clever, Decastin
- Lithuania · Kestine
- Luxembourg · Estivan, Estivan Lyo
- Latvia · Kestine
- Netherlands · Ebastine Aurobindo, Ebastine Smelt Teva
- Norway · Ebastin Orifarm, Kestine
- Poland · Evastix
- Portugal · Ebastina Alter, Ebastina Generis
- Sweden · Ebastin Abece, Ebastin Apofri
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f293ec75-a796-4017-82df-7824499c8b74 GET /v1/drugs/f293ec75-a796-4017-82df-7824499c8b74?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ebastine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ebastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.